A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 40,951 shares of PFE stock, worth $1.13 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
40,951
Previous 42,162 2.87%
Holding current value
$1.13 Million
Previous $1.21 Million 6.35%
% of portfolio
0.66%
Previous 0.75%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$25.89 - $29.73 $31,352 - $36,003
-1,211 Reduced 2.87%
40,951 $1.14 Million
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $137,234 - $178,252
-5,252 Reduced 11.08%
42,162 $1.21 Million
Q3 2023

Oct 03, 2023

BUY
$32.09 - $37.51 $26,024 - $30,420
811 Added 1.74%
47,414 $1.57 Million
Q2 2023

Jul 05, 2023

SELL
$36.12 - $41.79 $52,951 - $61,264
-1,466 Reduced 3.05%
46,603 $1.71 Million
Q1 2023

Apr 05, 2023

BUY
$39.39 - $51.28 $157 - $205
4 Added 0.01%
48,069 $1.96 Million
Q4 2022

Jan 17, 2023

SELL
$41.75 - $54.5 $17,702 - $23,108
-424 Reduced 0.87%
48,065 $2.46 Million
Q3 2022

Oct 07, 2022

BUY
$43.76 - $53.42 $52,512 - $64,104
1,200 Added 2.54%
48,489 $2.12 Million
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $33,548 - $39,777
721 Added 1.55%
47,289 $2.48 Million
Q1 2022

Apr 14, 2022

SELL
$45.75 - $56.69 $40,397 - $50,057
-883 Reduced 1.86%
46,568 $2.41 Million
Q4 2021

Jan 13, 2022

SELL
$41.32 - $61.25 $36,113 - $53,532
-874 Reduced 1.81%
47,451 $2.8 Million
Q3 2021

Oct 07, 2021

BUY
$39.25 - $50.42 $12,677 - $16,285
323 Added 0.67%
48,325 $2.08 Million
Q2 2021

Jul 13, 2021

SELL
$35.91 - $40.68 $22,048 - $24,977
-614 Reduced 1.26%
48,002 $1.88 Million
Q1 2021

Apr 08, 2021

SELL
$33.49 - $37.77 $31,045 - $35,012
-927 Reduced 1.87%
48,616 $1.76 Million
Q4 2020

Jan 12, 2021

SELL
$33.47 - $42.56 $3,246 - $4,128
-97 Reduced 0.2%
49,543 $1.82 Million
Q3 2020

Oct 13, 2020

SELL
$31.75 - $37.25 $75,279 - $88,319
-2,371 Reduced 4.56%
49,640 $1.82 Million
Q2 2020

Jul 08, 2020

BUY
$30.12 - $36.54 $29,577 - $35,882
982 Added 1.92%
52,011 $1.7 Million
Q1 2020

Apr 09, 2020

BUY
$27.03 - $38.62 $7,081 - $10,118
262 Added 0.52%
51,029 $1.67 Million
Q4 2019

Jan 08, 2020

SELL
$32.92 - $37.36 $35,191 - $39,937
-1,069 Reduced 2.06%
50,767 $1.99 Million
Q1 2019

Apr 17, 2019

SELL
$37.5 - $41.2 $90,262 - $99,168
-2,407 Reduced 4.44%
51,836 $2.2 Million
Q2 2018

Jul 13, 2018

BUY
$32.98 - $35.16 $1.79 Million - $1.91 Million
54,243 New
54,243 $1.97 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Murphy, Middleton, Hinkle & Parker, Inc. Portfolio

Follow Murphy, Middleton, Hinkle & Parker, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy, Middleton, Hinkle & Parker, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Murphy, Middleton, Hinkle & Parker, Inc. with notifications on news.